PSBIN caTissue Suite and caB2B 04/09/2012 Baris Suzek Andy Helsley Suhas Khot Dave Mulvihill.

Slides:



Advertisements
Similar presentations
Is Radical Prostatectomy Adequate For High Risk Prostate Cancer?
Advertisements

PROSTATE CANCER da Vinci Robot Surgery Cedric Emery, MD. FACS
NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
AJCC TNM Staging 7th Edition Thyroid Case #3
Biospecimen Banking has Evolved Highly Complex Informatics Requirements
Clinically localized prostate cancer: Prostatectomy David D. Thiel, MD Mayo Clinic Florida Department of Urology.
THE CLINICO-PATHOLOGIC PATTERNS OF PROSTATIC DISEASES AND PROSTATE CANCER IN SAUDI PATIENTS Hisham A. M. Mosli, FRCSC, FACS Taha A. Abdel-Meguid, MD Jaudah.
Role of Nodal Irradiation in Breast Cancer
Coding Pitfalls Jessica K. Dohler, BS, CTR. Objectives 0 Know how to code the Tumor/Ext Eval code when using intraoperative findings 0 Know when to code.
Epidemiology of prostate cancer Epidemiology and Molecular Pathology of Cancer: Bootcamp course Tuesday, 3 January 2012.
Carcinoma of the Prostate By: Ishan Parikh. Background on Cancer  Oldest information dates back to 3000 BC, Egyptian textbook on trauma surgery – “There.
Prostate Cancer Radical Prostatectomy
Racial Disparities and Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Cancer Xianglin L. Du, M.D., Ph.D.
Prostate cancer: early detection, monitoring and prognosis: Essex Biomedical Sciences Institute (EBSI) Elena Klenova, University of Essex the search for.
Analysis of Prostate Cancer Prevention Behavior in Florida Utilizing The 2002 BRFSS Data Yussif Dokurugu MPH Candidate April 9, 2004.
Radical Prostatectomy: A Critical Analysis of Surgical Quality Between the Open and Laparoscopic Approaches. Karim Touijer, MD.
Procedures used by CHTN
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Steven Joniau Filip Ameye
PROSTATE CANCER LETS DEBATE !!!! Dr Fred C Tyler MBChB FRCS FCS UROL.
Prostate Cancer Int. 洪 毓 謙. Prostate cancer is the Second leading cause of death from cancer in the United States American male, the lifetime risk of:
Objectives: Our first segment focused in the anatomy and functions of the prostate gland, to get a clear understanding of the male Genito-Urinary System.
© Cancer Research UK 2008 Registered charity number Prostate cancer – UK December 2009.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Cancer Survival Query System (CSQS): Making Survival Estimates from Population-Based Cancer Registries More Timely and Relevant for Recently Diagnosed.
CaTissue Suite 2.0 Scope Detail TBPT Workspace call May 23, 2011.
Howard M. Sandler, MD University of Michigan Medical School
CaBench-to- Bedside (caB2B) An easy to use tool for searching across caGrid Rakesh Nagarajan Washington University School of Medicine.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Prostate Cancer Prostate cancer is the most common cancer detected in American men. The lifetime risk of a 50-year-old man for latent CaP is 40%; for.
Dan Spratt, MD Department of Radiation Oncology Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging.
Mark L. Merlin, M.D. Radiotherapy Clinics of Georgia 7/14/2010 The Role of Radiation Therapy in the Management of Prostate Cancer.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Prostate Cancer Treatment: What’s Best For You?
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Fifth Annual African-American Prostate Cancer Disparity Summit September 24, 2009 Christine.
Diagnoses, Decisions, and Outcomes: Web Search as Decision Support for Cancer Michael J. Paul, Johns Hopkins University Ryen W. White and Eric Horvitz,
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
CASE 1 65-year-old man No other diseases or previous surgeries July 2005: PSA 11.5 ng/ml; F/T: 9% After prostate biopsy revealing adenocarcinoma: RETROPUBIC.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
JHH Prostate Cancer Prostate Cancer Cases Diagnosed 1999 – 2004 Analytic vs. Non-Analytic n=7776 * Analytic - Initially Diagnosed and/or received.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prediction of Erectile Function Following Treatment.
IMPACT OF STAGE MIGRATION ON NODE POSITIVE PROSTATE CANCER RATE AND FEATURES: A 20-YEAR, SINGLE INSTITUTION ANALYSIS IN MEN TREATED WITH EXTENDED PELVIC.
Surgical Treatment in Locally Advanced Prostate Cancer
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital
Bladder Cancer and Prostatic Cancer
PHEN Clinical Trials Rally
Principles of Surgical Oncology
Post Op Positive Apex Margins Case 3: Prostate_3
Surgical Cancer Treatment
Copyright © 2011 American Medical Association. All rights reserved.
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Post Op Positive Seminal Vesicle Case 4: Prostate_4
Prostate Cancer: Highlights from 2006
Apollo Gleneagles Hospitals,
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study  Stephen H. Culp, Paul.
Activities What’s for Dinner? Name: Period: Me
Fernando P. Secin, Fernando J. Bianco, Nicholas T
The Research Question 1) What is the contemporary prevalence of Active Surveillance (AS) adoption among men newly diagnosed with low-risk localized prostate.
Axial contrast-enhanced CT demonstrates a myocutaneous fat flap (white arrow) used for reconstruction following resection of a squamous cell carcinoma.
Presentation transcript:

PSBIN caTissue Suite and caB2B 04/09/2012 Baris Suzek Andy Helsley Suhas Khot Dave Mulvihill

Acknowledgements UCLA – Andy, Buddy Michigan - Radhika OHSU - Fred MSKCC - Ravi Baylor – Stephen, Heidi UWash – Xenia, Paul Northwestern - Dong UCSF – Sudeep Dana Farber - Paul

Deployment Package Base deployment package (current version includes Oracle Data Patch) For Linux/Unix: uctions.docx For Windows: ows.zip uctions_windows.docx

Data Loader Package A OHSU/UCLA development to import/export data – Community project caRuby Fixed as of 3/15/2012 – Updated the annotation service API clients – Fixed tiny.java for GleasonScore.XScore and GeneralHealthAnnotation.ageAtDiagnosis Another iteration of fixes 4/4/2012 – Focusing on data problems; how to handle empty values? E.g. Gleason Score

Patches Oracle Date Patch for caGrid Services Empty Objects Patch for caTissue Suite Annotation API Gleason Score Patch for caTissue Suite Pathology Annotation for SCG API and its caGrid Service cats_pcbin_participant API war fix – Customizing UMichigan war at respective sites – Following instructions from TBPT KC

Current Status – Deployments UCLAMichiga n OHSUMSKCCBaylorUWashNorthwesternUCSFDana Farber Base Pkg Done ? Planned Oracle Date Done N/ADoneN/A Done? Empty Object Done In progress Done ? Planned Gleas on Score Done In progress Done ? Planned cats_p cbin Done N/ADone Planned?DonePlanned Query from UCLA caB2B Done Pending firewall DonePending firewall Done?Pending firewall Planned Data load Planne d DonePlannedIn progress PlannedDonePlanned

Current Status - Queries #0: Give me all participants #1: Which frozen tissue samples are available for black or African American men who were diagnosed after 2005 and had a pre-treatment PSA > 10? – PSA (LabAnnotation.result) is not numeric so instead of numeric comparison option to use equal with PSA #2: Which samples are available for men diagnosed over age 60 with clinical tumor stage T2a or T2b and biopsy gleason total > 6? – Tertiary Score is used for Gleason total; the data loader loads the total to this data element #3: Which samples are available for men with biospy gleason 3+4 or 4+3 (primary+secondary) who had neoadjuvant hormone therapy?

Current Status - Queries #4: Which samples are available for men who had surgery before 2007, were over 65 years old at the time of surgery, and had prostatectomy gleason > 3 (in either primary or secondary gleason)? #5: Which samples are available for men who had a prostatectomy with Gleason total <6, surgical margins uninvolved by invasive carcinoma, absent extra prostatic extension, and absent lymphatic invasion? #6: Which samples are available for men who had adjuvant hormone therapy or adjuvant radiation therapy?

Current Status - Queries

Next Steps caB2B – Enhancements/features – Demo Data loads – UCLA, Baylor, MSKCC, OHSU, UWash, UCSF, Dana Farber caGrid deployments – Northwestern, Dana Farber